BeStock  

ANI Pharmaceuticals ANIP

US equityMarket cap rank #2847Drug Manufacturers - Specialty & Generic
$68.55 −$0.58 (-0.84%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $68.55 0.00%
Open$68.96
Prev close$69.13
Day range$68.28 – $70.20
Volume227.3K
Market cap$1.56B
P/E (TTM)13.6
Dividend yield–

ANIP Stock News

Headlines matching ANI Pharmaceuticals or the ANIP ticker, most recent first.

  • Leerink Partners Initiates ANI Pharmaceuticals(ANIP.US) With Buy Rating, Announces Target Price $104Market news · 9 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $121Market news · 22 Sep 2026 · Direct mention
  • Barclays Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $100Market news · 26 Aug 2026 · Direct mention
  • J.P. Morgan Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $115Market news · 10 Aug 2026 · Direct mention
  • Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Cuts Target Price to $119 NegativeMarket news · 10 Aug 2026 · Direct mention
  • CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Cuts Target Price to $90 NegativeMarket news · 10 Aug 2026 · Direct mention
  • CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $91Market news · 17 Jul 2026 · Direct mention
  • CCORF Downgrades ANI Pharmaceuticals(ANIP.US) to Hold Rating, Raises Target Price to $91 MixedMarket news · 17 Jul 2026 · Direct mention
  • Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $124Market news · 14 Jul 2026 · Direct mention
  • Truist Financial Maintains ANI Pharmaceuticals(ANIP.US) With Hold RatingMarket news · 11 May 2026 · Direct mention
  • Piper Sandler Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $111 PositiveMarket news · 23 Apr 2026 · Direct mention
  • Jefferies Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $120 PositiveMarket news · 25 Mar 2026 · Direct mention
  • H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $121Market news · 6 Nov 2026 · Direct mention
  • CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $90Market news · 6 Nov 2026 · Direct mention
  • Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $121 PositiveMarket news · 6 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ANIP.

Sign in to join the discussion.

Scroll to Top